Fagron NV (FAGR)
Euronext
Real-time Data
07:00 AM
Day's Range
22.2552 wk Range
19.24Overview - FAGR - Fagron NV
Key Statistics
Valuation
Enterprise Value
2.14B
P/E (Trailing)
‪17.84‬
P/E (Forward)
‪13.56‬
Price / Sales (TTM)
‪1.59‬
Price / Book
‪2.75‬
EV / EBITDA
‪12.29‬
Profitability
Profit Margin
‪8.91%‬
Operating Margin
‪13.72%‬
Return on Assets
‪6.97%‬
Return on Equity
‪16.70%‬
Ownership
Shares Outstanding
73.34M
Float
65.85M
Held by Insiders
‪0.29%‬
Held by Institutions
‪71.67%‬
Price stats
Beta
‪0.38‬
50-Day Avg
‪23.43‬
200-Day Avg
‪22.68‬
Dividends
Payout Ratio
‪32.00%‬
Analyst Consensus
6 analysts
Average price target
‪€ 28.75‬Market Cap - FAGR - Fagron NV
Peers - FAGR - Fagron NV
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Euronext.
- FAGREuronextFagron NV1.63BMarket Cap+7.61%52-week change17.88P/E (Trailing)‪8.91%‬Profit Margin
- IPNEuronextIpsen S.A.13.69BMarket Cap+28.93%52-week change26.84P/E (Trailing)‪11.94%‬Profit Margin
- BOIEuronextBoiron SA446.21MMarket Cap+17.38%52-week change13.83P/E (Trailing)‪6.51%‬Profit Margin
- BONEuronextBonduelle SCA282.80MMarket Cap+11.16%52-week change13.22P/E (Trailing)‪2.27%‬Profit Margin
- EAPIEuronextEuroapi S.A.S.U.89.93MMarket Cap-222.52%52-week change8.84P/E (Trailing)‪-40.80%‬Profit Margin
- ABEuronextAB Science S.A.68.82MMarket Cap-68.86%52-week change-23.77P/E (Trailing)‪-132.62%‬Profit Margin
- PAREuronextParef SA37.88MMarket Cap-48.80%52-week change20.04P/E (Trailing)‪-47.65%‬Profit Margin
Profile Summary - FAGR - Fagron NV
About
Fagron NV is a publicly traded multinational company governed by Belgian law, specializing in pharmaceutical compounding to enable personalized medicine for hospitals, pharmacies, clinics, and patients worldwide. Headquartered in Rotterdam, Netherlands, with its registered office in Waregem, Belgium, it supplies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
